Vorasidenib in CNS WHO Grade 2 IDH-mutant Diffuse Glioma
Clinical trial NCT07240662 · RECRUITING
Trial details
- NCT number
- NCT07240662
- Sponsor
- iOMEDICO AG
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-12-08
- Primary completion
- 2031-11-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.